PROPANC BIOPHARMA INC (PPCB) Stock Balance Sheet
NASDAQ:PPCB - Nasdaq - US74346N7012 - Common Stock - Currency: USD
| MRQ (2024-12-31) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 14.60K | 21.10K | 10.10K | 4.10K | 2.30K | |||
| Receivables | 2.00K | 3.00K | 2.90K | 2.30K | 4.30K | |||
| Other Current Assets | 1.40K | 1.40K | 6.10K | 8.60K | N/A | |||
| Total Current Assets | 18.00K | 25.40K | 19.00K | 15.00K | 6.60K | |||
| Non-Current Assets | ||||||||
| PPE Net | 6.60K | 17.80K | 39.30K | 64.60K | 4.30K | |||
| Other Non-Current Assets | 54.00K | 29.10K | 2.00K | 2.10K | 2.30K | |||
| Total Non-Current Assets | 60.50K | 47.00K | 41.30K | 66.70K | 6.50K | |||
| TOTAL ASSETS | 78.50K | 72.40K | 60.30K | 81.70K | 13.10K | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 1.12M | 870.30K | 505.10K | 1.04M | 680.10K | |||
| Accrued Expenses | 1.52M | 1.45M | 1.19M | 902.50K | 1.31M | |||
| Accounts Payable | 1.36M | 1.31M | 1.01M | 943.00K | 1.00M | |||
| Other Current Liabilities | 159.10K | 163.70K | 452.80K | 182.00K | 87.60K | |||
| Total Current Liabilities | 4.16M | 3.79M | 3.16M | 3.06M | 3.08M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 82.30K | 58.60K | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | 0.00 | 19.30K | 42.30K | N/A | |||
| Total Non-Current Liabilities | 82.30K | 58.60K | 19.30K | 42.30K | 0.00 | |||
| TOTAL LIABILITIES | 4.24M | 3.85M | 3.18M | 3.11M | 3.08M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -67.48M | -66.70M | -64.68M | -61.58M | -58.20M | |||
| Additional Paid In Capital | 61.88M | 61.22M | 60.31M | 57.13M | 54.07M | |||
| Common Shares | 0.00 | 478.80K | 7.70K | 245.00K | 19.10K | |||
| Treasury Stock | -46.50K | -46.50K | -46.50K | -46.50K | -46.50K | |||
| Other Shareholders' Equity | 1.49M | 1.27M | 1.29M | 1.23M | 1.09M | |||
| Shares Outstanding | 14.50K | 9.60K | 100.00 | 0.00 | 14.10K | |||
| Tangible Book Value per Share | -286.61 | -394.47 | -25.98K | -13.74 | -218.53 | |||
| Total Shareholders' Equity | -4.16M | -3.78M | -3.12M | -3.02M | -3.07M | |||
| TOTAL LIABILITIES AND EQUITY | 78.50K | 72.40K | 60.30K | 81.70K | 13.10K | |||
| Statistics | ||||||||
| Debt/Equity | -0.29 | -0.25 | N/A | N/A | N/A | |||
| Current Ratio | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | |||
| Return On Assets (ROA) | -2147.26% | -2781.08% | -5185.41% | -3253.49% | -15465.65% | |||
All data in USD , ROIC based on taxRate of 0.21